Abstract: As the field advances with the introduction of a new generation of electrodes, the demand for refined injection methodologies becomes evident. These electrodes, frequently termed ...
The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's what we know.
TREMFYA® offers the flexibility of self-administration from the start of treatment, building on the prior approval of subcutaneous induction in Crohn's ...
Under brand names like Wegovy and Ozempic, semaglutide assists weight loss and manages diabetes through a series of daily injections. Unfortunately, the small sting that's required with every dose can ...
Introduction The infrapatellar fat pad and synovium are the sites of immune cell infiltration and the origin of proinflammation. Studies have shown that Hoffa’s synovitis may be a sign of early-stage ...
KEYTRUDA QLEX is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute RAHWAY, N.J., September 19, ...
The FDA approved subcutaneous pembrolizumab and berahyaluronidase alfa-pmph for solid tumors in patients 12 years or older. Recommended dosages are 395 mg/4800 U every 3 weeks or 790 mg/9600 U every 6 ...
Subcutaneous pembrolizumab with berahyaluronidase alfa is FDA-approved for all solid tumor indications, including metastatic nonsquamous NSCLC. The phase 3 3475A-D77 trial confirmed noninferior ...
MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage ...
- In preclinical studies presented today at the RNA Leaders USA Congress 2025, investigational ARO-MAPT demonstrated potent and long-lasting MAPT mRNA and Tau protein suppression with uniform ...
Zepbound (tirzepatide) and Ozempic (semaglutide) are brand-name subcutaneous injections. They’re both prescribed for weight loss and weight management, but only Zepbound has been FDA-approved for this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback